Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2021

Aug 25, 2021

32853_dirs_2021-08-24_02e9bbec-2867-4583-a68e-7d704da0f24a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-08-20

Reporting Person: Khadder Nicholas (SVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-20 Common Stock M 4062 Acquired 79199 Direct
2021-08-20 Common Stock F 2013 $6.53 Disposed 77186 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-20 Restricted Stock Units $ M 4062 Disposed Common Stock (4062.0) Direct

Footnotes

F1: Includes 1,057 shares purchased on May 28, 2021 under the Company's 2017 Employee Stock Purchase Plan.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.